Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 5/20 | 0.58 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.57 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | XIAP | P98170 | 1/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
| ▸ | LTA4H | P09960 | 3/20 | 0.54 |
| ▸ | MME | P08473 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9628000 | 1.00 | ACE (0.58) | ACENAALAD2ALPIPKMPTGS1 | |
| SCHEMBL161657 | 1.00 | ACE (0.58) | ACENAALAD2ALPIPKMPTGS1 | |
| SCHEMBL18222588 | 1.00 | ACE (0.58) | ACENAALAD2ALPIPKMPTGS1 | |
| Glutamic Acid SCHEMBL4387195 | 0.96 | NAALAD2 (0.64) | ACENAALAD2ALPIPKMPTGS1 | |
| D-Glutamate SCHEMBL4387193 | 0.96 | NAALAD2 (0.64) | ACENAALAD2ALPIPKMPTGS1 | |
| Methylmalonic Acid SCHEMBL29577852 | 0.93 | ACE (0.52) | ACENAALAD2ALPIPKMPTGS1 | |
| SCHEMBL15345879 | 0.91 | LTA4H (0.62) | ACELTA4HMME | |
| SCHEMBL30803739 | 0.90 | NAALAD2 (0.61) | ACENAALAD2MME | |
| SCHEMBL159886 | 0.89 | NAALAD2 (0.59) | ACENAALAD2SLC7A5MME | |
| SCHEMBL159887 | 0.89 | NAALAD2 (0.59) | ACENAALAD2SLC7A5MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 305 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250270602-A1 | STRAIN OF MICROORGANISMS AND PROCESS FOR THE FERMENTATIVE PRODUCTION OF GAMMA-GLUTAMYLTYROSINE AND GAMMA-GLUTAMYLPHENYLALANINE | WACKER CHEMIE AG (DE) | 2025-08-28 | — | — | US | claimed |
| CN-119780446-A | Biomarker for milk cow early pregnancy related state and application thereof | 宁夏大学 | 2025-04-08 | — | — | CN | claimed |
| WO-2025016303-A1 | GLP-1, GIP AND GCG RECEPTOR TRIAGONIST AND USE THEREOF | 北京拓界生物医药科技有限公司 | 2025-01-23 | — | — | WO | claimed |
| US-20240426830-A1 | CHRONIC WOUND HEALING BIOMARKER DIAGNOSTICS | THE TRUSTEES OF INDIANA UNIVERSITY | 2024-12-26 | — | — | US | claimed |
| CN-116508912-B | Fishing regulation composition with lipid-lowering and blood sugar-controlling functions, and preparation method and application thereof | 华南农业大学 | 2024-12-10 | — | — | CN | claimed |
| EP-3969903-B1 | METHOD OF SELECTING SKIN TREATMENT REGIMENS, INGREDIENTS AND COMPOSITIONS | JOHNSON & JOHNSON CONSUMER INC (US) | 2024-10-09 | — | — | EP | claimed |
| US-12050228-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2024-07-30 | — | — | US | claimed |
| CN-117612741-A | Novel coronavirus infection metabolic profile, and construction method, device, system and application thereof | 首都医科大学附属北京朝阳医院 | 2024-02-27 | — | — | CN | claimed |
| WO-2023233945-A1 | BILIARY TRACT CANCER TESTING METHOD | 株式会社日立ハイテク | 2023-12-07 | — | — | WO | claimed |
| CN-114373510-B | Metabolic marker for diagnosing or monitoring lung cancer and screening method and application thereof | 武汉迈特维尔医学科技有限公司 | 2023-12-01 | — | — | CN | claimed |
| WO-2014068144-A1 | BIOMARKERS OF MULTIPLE MYELOMA DEVELOPMENT AND PROGRESSION | OSPEDALE SAN RAFFAELE S.R.L. (IT) | 2014-05-08 | — | — | WO | claimed |
| US-8658351-B2 | Determining liver toxicity of an agent using metabolite biomarkers | METABOLON, INC. (US) | 2014-02-25 | — | — | US | claimed |
| WO-2013133715-A1 | CULTURE MEDIUM FOR EUKARYOTIC CELLS | FRIESLAND BRANDS B.V. (NL) | 2013-09-12 | — | — | WO | claimed |
| WO-2013133714-A1 | CULTURE MEDIUM FOR EUKARYOTIC CELLS | FRIESLAND BRANDS B.V. (NL) | 2013-09-12 | — | — | WO | claimed |
| US-20130224855-A1 | CULTURE MEDIUM FOR EUKARYOTIC CELLS | FRIESLANDCAMPINA NEDERLAND HOLDING B.V. (NL) | 2013-08-29 | — | — | US | claimed |
| EP-2611904-A2 | CULTURE MEDIUM FOR EUKARYOTIC CELLS | Friesland Brands B.V. (NL) | 2013-07-10 | — | — | EP | claimed |
| WO-2013070839-A1 | BIOMARKERS FOR BLADDER CANCER AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-05-16 | — | — | WO | claimed |
| EP-2227689-B1 | BIOMARKERS FOR FATTY LIVER DISEASE AND METHODS USING THE SAME | METABOLON INC (US) | 2012-12-26 | — | — | EP | claimed |
| WO-2012030217-A2 | CULTURE MEDIUM FOR EUKARYOTIC CELLS | FRIESLAND BRANDS B.V. (NL) | 2012-03-08 | — | — | WO | claimed |
| EP-0266905-A1 | Reagents for assay of gamma-glutamyl-transpeptidase | UNITIKA LTD. (JP) | 1988-05-11 | — | — | EP | claimed |